Office of Research & Development |
|
Project Number: I01CX001449-01A1
Title: Frequent, Low-Dose Erythropoietin: A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin Therapy in Patients with Chronic Kidney Disease
Principal Investigator: Mark S. Segal
FY 2018 Funding Amount: $199,734
Location: Gainesville, FL Research Service: Clinical Science R&D Project Period: October 2017 - September 2022 |